Subscribe To

Price Alert Latest News Economic Calendar News

CAH / Dividend Income Update July 2023

July was exciting as ever as my year-over-year numbers continue to highlight the trifecta magic of dividend investing, which includes adding fresh capital, dividend raises and basic compounding to create an ever increasing passive income stream. I have to say I'm quite pleased with my July totals. Not too far from that coveted four-digit milestone too. After all, dividends don't lie. It's real cash being returned to investors. With patience and consistency these results and better can be achieved. Read More

Demo Live Account See Partner Details

Content Topics

Dividend

Income

Update

July

2023

Stock

CAH

Posted: Aug 7 2023, 11:24

Author Name: Seeking Alpha

CAH News

By Zacks Investment Research
November 3, 2023

Cardinal Health (CAH) Beats on Q1 Earnings, Ups '24 EPS View

Cardinal Health's (CAH) first-quarter fiscal 2024 results benefit from the Pharmaceutical segment's solid performance.

By Zacks Investment Research
November 3, 2023

Cardinal Health (CAH) Surpasses Q1 Earnings and Revenue Estimates

Cardinal Health (CAH) came out with quarterly earnings of $1.73 per share, beating the Zacks Consensus Estimate of $1.40 per share. This compares to e

By Market Watch
November 3, 2023

Cardinal Health's stock rises into record territory after profit beat, raised outlook

Shares of Cardinal Health Inc. CAH, +0.21% climbed 1.3% into record territory in premarket trading Friday, after the drug distributor reported fiscal

By Zacks Investment Research
November 1, 2023

What's in Store for Cardinal Health (CAH) in Q1 Earnings?

Cardinal Health's (CAH) first-quarter fiscal 2024 results are expected to reflect solid performance in the Pharmaceutical segment.

By Zacks Investment Research
October 11, 2023

Is Cardinal Health (CAH) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Neverthe

By Zacks Investment Research
October 11, 2023

Reasons to Add Cardinal Health (CAH) in Your Portfolio

Cardinal Health (CAH) continues to gain traction from solid pharmaceutical segment and a diversified product portfolio. However, the rising cost of pr

By InvestorPlace
October 11, 2023

The Top 7 Stocks to Own During a Downturn

As uncertainty seems to dominate, it might be time to look for stocks to own during a downturn. For 10 straight months, investors enjoyed a strong com

By Zacks Investment Research
October 9, 2023

Cardinal Health (CAH) is a Top-Ranked Value Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.